BRIGHT MINDS BIOSCIENCES INC.
Disclosed SEC business address
400 N ABERDEEN ST SUITE 900, CHICAGO, IL, 60642
BRIGHT MINDS BIOSCIENCES INC. (ticker DRUG, CIK 0001827401) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
You've reached this month's free company deep views
The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.
Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:38:15.681698+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:38:19.741847+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:38:13.657232+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-11-04T20:38:17.694746+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.